scispace - formally typeset
O

Oliver Kemper

Researcher at Weizmann Institute of Science

Publications -  17
Citations -  2289

Oliver Kemper is an academic researcher from Weizmann Institute of Science. The author has contributed to research in topics: Tumor necrosis factor alpha & Receptor. The author has an hindex of 13, co-authored 17 publications receiving 2239 citations.

Papers
More filters
Journal ArticleDOI

Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.

TL;DR: The soluble forms of the TNF‐Rs are structurally identical to the extracellular cytokine binding domains of these receptors and are consistent with the notion that the soluble forms are, at least partly, derived from the same transcripts that encode the cell surface receptors.
Journal ArticleDOI

Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.

TL;DR: The findings suggest that signalling and shedding of the p55 TNF‐R are mechanistically distinct.
Patent

Expression of the recombinant tumor necrosis factor binding protein i (tbp-i)

TL;DR: Tumor Necrosis Factor Binding Protein I (TBP-I) precursors and analogs thereof, are produced by transfecting eukaryotic cells with an expression vector comprising al DNA molecule encoding the whole human type I TNF receptor or a soluble domain thereof, whereby the soluble proteins are secreted into the medium as discussed by the authors.
Journal Article

Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1.

TL;DR: In cells of the fibroblastoid line SV-80, rapid down-modulation of TNF binding in response to TNF itself, or to IL-1, was followed by a gradual recovery of binding, which occurred even in the continuous presence of the cytokines.